PMD Psychemedics Corp: רווח נקי למניה בארבעת הרבעונים האחרונים

The annual growth of basic net income per share (TTM) on the GURU.Markets terminal chart demonstrates yield dynamics, where the value of -88.30 characterizes this level. Psychemedics dominates the hair analysis segment, offering benchmark diagnostic accuracy per quarter. Government contracts and telemedicine provide positive momentum, although laboratory underutilization has temporarily reduced margins due to rising unit costs.

This metric reflects the trailing twelve-month (TTM) net income per share, neutralizing short-term fluctuations in quarterly reporting. It measures the business's ability to scale profitability relative to operating expenses. For Psychemedics (PMD), the absence of debt and the stability of the laboratory segment make this indicator a reflection of real capital efficiency. By analyzing the 12-month YoY EPS growth chart on GURU.Markets, an investor can assess earnings sustainability without the risk of overleverage.